Susan L. Kelley

Overexpression of Metallothionein Confers Resistance to Anticancer Drugs

Susan L. Kelley, Alakananda Basu, Beverly A. Teicher et al. · Science · 1988 · 605 citations

Medicine, Oncology, Pharmacology +13

CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris

Judith R. Abrams, Mark Lebwohl, Cynthia Guzzo et al. · Journal of Clinical Investigation · 1999 · 598 citations · Full text

Life Sciences, Dermatology, Immunology +17

Blockade of T Lymphocyte Costimulation with Cytotoxic T Lymphocyte–Associated Antigen 4–Immunoglobulin (Ctla4ig) Reverses the Cellular Pathology of Psoriatic Plaques, Including the Activation of Keratinocytes, Dendritic Cells, and Endothelial Cells

Judith R. Abrams, Susan L. Kelley, Elizabeth Hayes et al. · The Journal of Experimental Medicine · 2000 · 319 citations · Full text

Life Sciences, Immunology, Pathology +17

Phase 1 study of pomalidomide MTD, safety, and efficacy in patients with refractory multiple myeloma who have received lenalidomide and bortezomib

Paul G. Richardson, David S. Siegel, Rachid Baz et al. · Blood · 2012 · 161 citations · Full text

Medicine, Oncology, Pharmacology +15

Insulin independence in type I diabetes after transplantation of unpurified islets from single donor with 15-deoxyspergualin

Paul F. Gores, John S. Najarian, E. Stephanian et al. · The Lancet · 1993 · 161 citations

Medicine, Endocrinology, Surgery +14